Table 1 Demographics and baseline characteristics

From: Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

Characteristics

AZL-M 40

AZL-M 80

RAM 10

Number

295

294

295

Male (%)

53.9

53.7

49.5

Age (years)

56.9±11.5

56.8±11.3

56.8±10.5

BMI (kg m−2)

29.6±4.8

29.5±4.7

29.5±4.6

Clinic SBP (mm Hg)

160.7±7.3

161.4±7.7

161.2±8.5

Clinic DBP (mm Hg)

94.7±9.5

95.6±8.7

94.5±8.9

ABPM 24 h mean SBP (mm Hg)

140.7±1.0

139.5±1.0

141.0±1.0

ABPM 24 h mean DBP (mm Hg)

86.4±0.8

86.0±0.7

86.7±0.8

ABPM mean daytime SBP (mm Hg)

143.5±12.7

142.3±13.5

143.4±11.6

ABPM mean daytime DBP (mm Hg)

89.2±9.6

88.0±10.0

88.8±10.1

ABPM mean nighttime SBP (mm Hg)

128.9±14.7

126.4±14.4

128.0±12.8

ABPM mean nighttime DBP (mm Hg)

75.5±11.1

74.0±9.9

74.9±10.7

  1. Abbreviations: ABPM, ambulatory blood pressure monitoring; AZL-M, azilsartan medoxomil; BMI, body mass index; DBP, diastolic blood pressure; RAM, ramipril; SBP, systolic blood pressure.
  2. No statistically significant differences.